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A B S T R A C T
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children younger than 15 years. According to
the World Health Organization, there are embryonal, alveolar and pleomorphic types of RMS. Most RMS patients pres-
ent with a tumor mass in the head and neck region, urogenital tract or lower extremities. Unusual clinical presentation
of the disease with massive bone marrow infiltration at the disease onset and mimicking hematologic neoplasm is rarely
seen. A case is presented of a 14-year-old, previously healthy girl hospitalized for outpatiently detected leukocyte eleva-
tion. For the last two weeks, she had complained of fatigue, myalgia and frequent bruising. On admission, clinical exam-
ination revealed numerous petechiae and hematomas, enlarged left inguinal lymph node and palpable spleen 2 cm below
left costal arch. Laboratory findings showed leukocytosis, anemia and thrombocytopenia. Bone marrow fine needle aspi-
ration (FNA) produced a hypercellular bone marrow sample with suppression of all three hemocytopoiesis lines and bone
marrow infiltration with numerous undifferentiated tumor cells. Considering the morphological, cytochemical and phe-
notypic characteristics, the cytologic diagnosis was: bone marrow infiltration with RMS cells. Abdominal computerized
tomography revealed a primary tumor occupying the entire retropeoritoneal space. Tumor biopsy confirmed alveolar sub-
type of RMS. In conclusion, in cases of bone marrow infiltration with primitive, immature cells, RMS should be consid-
ered as differential diagnostic possibility. Adjuvant technologies (cytochemistry, immunocytochemistry, cytogenetic anal-
ysis, flow cytometry, and molecular analysis) can be very helpful in diagnostic work-up, and may lead to definitive
diagnosis in some cases.
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Introduction
Rhabdomyosarcoma (RMS) is the most common soft
tissue sarcoma in children younger than 15 years1,2. RMS
accounts for 4–5% of all tumors in pediatric patients3 and
is one of the most common soft tissue sarcomas in adoles-
cents and adults1. RMS rarely occurs after age of 451. Ac-
cording to World Health Organization classification, the-
re are three RMS subtypes: embryonal, alveolar and
pleomorphic RMS2. Embryonal RMS is the most common
subtype1,2,4, accounting for 50–60% of all RMS cases1. It
most frequently develops in children under age 151,2,
with as many as 46% of cases recorded in children youn-
ger than 5 years2. It is mostly localized in the head and
neck region1,2 (about 47% of cases)2, followed by the geni-
tourinary system and retroperitoneum, and extremi-
ties1,2. This tumor typically develops in the orbit, nasal
cavity, middle ear, prostate and paratesticular region4.
Unlike embryonal RMS, the second most common alveo-
lar RMS occurs predominantly in adolescents and young
adults, less frequently in pediatric patients1,2,4. Extrem-
ities are the most common seat of alveolar RMS2,4 (about
39%), followed by the paraspinal and perineal region and
paranasal sinuses2. Pleomorphic RMS is the rarest form1,2
which almost exclusively occurs in adults2, predominan-
tly in the region of large muscles of extremities1,2,4.
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Rhabdomyoblast is a diagnostic cell in all RMS sub-
types. Rhabdomyoblast has eccentrically positioned eo-
sinophilic granular cytoplasm. Rhabdomyoblast can be
rounded or elongated, known as tadpole or strap cells,
and can show striated pattern under light microscope4.
RMS phenotype depends on the degree of rhabdomyo-
blast differentiation. On immunocytochemistry, the most
primitive tumor cells are only positive for vimentin, how-
ever, further differentiation renders them positive for
desmin and muscle-specific actin, whereas the cells with
the highest degree of differentiation are positive for
myoglobin and myosin2,5. Antibodies to MyoD11,2,5 and
myogenin show high specificity and sensitivity for RMS2.
Embryonal and alveolar RMS shows various gene alter-
ations. A characteristic t(2,13)(q35;q14) translocation is
detected in most cases of alveolar RMS2–4, while t(1;13)
(p36;q14) translocation is less common2,4. In embryonal
RMS, the loss of heterozygosity (LOS) is found on 11p15
locus, with the loss of maternal and duplication of pater-
nal genetic material2,3.
Clinically, most tumors present as a solid tumor mass
in the head and neck region, genitourinary tract or
extremities6. In 20% of cases, metastases are present at
the time of diagnosis. The most common sites of meta-
stases are the lungs (involved in 2/3 of cases with me-
tastases), lymph nodes and bone marrow1. RMS is one of
the rare sarcomas that metastasize to local lymph nodes.
Case Report
A 14-year-old female patient was admitted to the hos-
pital for suspected hemoblastosis. There were no serious
diseases in her medical history. The patient presented
with severe myalgia that had persisted for a week, poor
appetite, fatigue and frequent bruising. Upon admission,
the patient’s clinical status revealed numerous petechiae
and hematomas on the skin, left inguinal lymph node en-
largement of 5 cm in diameter, palpable liver margin and
palpable spleen 2 cm below the left costal arch. Labora-
tory findings: leukocytosis (white blood cell count of
28.5´109/L), anemia (red blood cell count of 3.02´1012/L;
hemoglobin of 85 g/L), thrombocytopenia (platelet count
of 15´109/L), elevated lactate dehydrogenase (6620 U/L)
and elevated C-reactive protein (27.1 mg/L). Bone mar-
row FNA produced a hypercellular bone marrow sample
with suppression of all three hematopoetic cell lines and
bone marrow infiltration with primitive, immature, me-
dium-sized cells. The cells were mostly single, partly in
small clusters and 'rosettes', with reticular chromatin
structure, and moderate to abundant, frequently finely






Fig. 1. a and b) tumor cells in bone marrow aspirate (May-Grünwald-Giemsa, x1000), c) vimentin pozitive tumor cells in bone marrow
aspirate (immunocytochemistry, LSAB x1000), d) desmin pozitive tumor cells in bone marrow aspirate (immunocytochemistry, LSAB
x1000).
vacuolated and in part elongated cytoplasm. Immuno-
cytochemistry and cytochemistry staining revealed the
cells to be negative for LCA, CD20, CD19, CD3, CD10,
NSE, Ber EP 4, oil red, peroxidase and alpha-naphthyl ac-
etate esterase, and strongly positive for PAS, vimentin
and in part for desmin and CD68 (Figure 1). The cytolo-
gist believed it was a case of bone marrow infiltration
with malignant small cell tumor that corresponded best
to RMS according to its morphology, cytochemistry and
immunocytochemistry characteristics. Tumor cells of the
same type were also found in peripheral blood smears
(3%) and enlarged inguinal lymph node FNA sample
(Figure 2). Cytogenetic analysis of the bone marrow aspi-
rate showed the following karyotype: 46~47,XX,der(2),
del(2p), add(2q),–13,+r(1–2)[15]/[15]. Bone marrow im-
munophenotyping by flow cytometry showed the blast/
monocyte sized cells not to express the pan-leukocyte
marker CD45 or any of the lymphoid or myeloid line mar-
kers, with the exception of the adhesion molecules CD56
and CD138. PCR analysis of bone marrow for IgH and
TCR gamma gene rearrangement failed to demonstrate
clonal rearrangement.
Primary tumor was found by abdominal CT, which
showed a large tumor mass that occupied the entire
retroperitoneal space, descending to the pelvis. Enlarged
spleen and enlarged retroperitoneal and inguinal lymph
nodes were also observed. Thoracic CT revealed enlarged
bronchopulmonary lymph nodes. Retroperitoneal tumor
biopsy confirmed it to be RMS of alveolar subtype. His-
tologically, tumor tissue was composed of solid rounded
cell clusters with occasional fibrovascular septa between
them, in part showing the pattern of alveolar formations.
Immunohistochemically, tumor cells were negative for
LCA, CD10, CD20, CD43, TDT, MIC2, NSE, NF and
cytokeratin, and positive for vimentin, actin and desmin.
Discussion
The case presented showed an unusual and very rare
clinical picture of RMS, mimicking clinical picture of
acute leukemia with typical clinical symptoms and signs
such as pancytopenia and presence of primitive imma-
ture cells in the bone marrow and peripheral blood. Ac-
cording to the Intergroup Rhabdomyosarcoma Study re-
port, bone marrow infiltration found at the time of
diagnosis was recorded in 29% of RMS patients in clinical
stage IV (disease dissemination with metastases)8. Alveo-
lar RMS was diagnosed in as many as half of the pa-
tients8, which is consistent with the hypothesis on alveo-
lar RMS to have a higher tendency to disseminate than
embryonal RMS8,9. Although RMS can metastasize to
bone marrow, it very rarely presents with the symptoms
and signs associated with bone marrow infiltration by
foreign cells as the initial and sole disease manifestation,






Fig. 2. a and b) tumor cells in lymph node aspirate (May-Grünwald-Giemsa, x1000), c) LCA negative tumor cells in lymph node aspirate
(immunocytochemistry, LSAB x1000), d) tumor cells in peripheral blood smear (May-Grünwald-Giemsa, x1000).
thus imitating the clinical picture of hemoblastosis7,8,10,11.
Therefore, cytomorphologist should consider RMS on
differential diagnosis in patients with primitive imma-
ture cells found in the bone marrow and peripheral
blood. The poorly differentiated forms of RMS composed
of small, uniform, poorly differentiated cells are difficult
to distinguish morphologically from hemoblastosis and
other small blue cell tumors of childhood such as neuro-
blastoma, Ewing sarcoma, peripheral neuroectodermal
tumor, non-Hodgkin’s lymphoma, Wilms’ tumor, small
cell hepatoblastoma, pancreaticoblastoma, small cell des-
moblastic tumor, and seminoma1,12,13. Additional cyto-
chemistry and immunocytochemistry staining is crucial
to reach an accurate diagnosis6,7,10. In the case presented,
cytochemistry staining of bone marrow FNA smears re-
vealed the tumor cells to be negative for myeloid markers
(peroxidase, alpha-naphthyl acetate esterase) and posi-
tive for PAS, which is seen in leukemia and lymphoma,
but also in RMS6. The RMS phenotype depends on the
degree of differentiation. On immunocytochemistry, the
most primitive tumor cells are only positive to vimentin,
to be rendered positive for desmin and muscle-specific
actin by further differentiation, whereas the best differ-
entiated cells are also positive for myoglobin and myo-
sin2,5. In our patient, tumor cells in the bone marrow
FNA sample were positive for vimentin and desmin on
immunocytochemistry, while immunohistochemistry stai-
ning of the retroperitoneal tumor biopsy sample revealed
positivity for vimentin, muscle-specific actin and desmin.
Although cytogenetic studies have demonstrated the
t(2,13)(q35;q14) translocation and less commonly the
t(1,13)(p36;q14) translocation to be characteristic of al-
veolar RMS2–4, others have reported the presence of addi-
tional chromosomal material, also involving chromosome
2; add(2)(q37), in RMS cases6,14,15. In our patient, the
characteristic t(2,13)(q35;q14) translocation was not found
either, but the mentioned add(2q) aberration, already re-
corded in RMS cases6,14,15, was present, along with other
chromosomal aberrations involving chromosomes 2 and
13: 46~47,XX,der(2),del(2p),add(2q), –13,+r(1–2)[15]/[15].
In case of bone marrow infiltration with primitive im-
mature cells, RMS should be taken in consideration on
differential diagnosis, whereby adjuvant technologies such
as cytochemistry, immunocytochemistry, cytogenetic anal-
ysis, flow cytometry16 and molecular analysis can prove
very useful and in some cases may lead to definitive diag-
nosis.
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INFILTRACIJA KO[TANE SR@I STANICAMA RABDOMIOSARKOMA
S A @ E T A K
Rabdomiosarkom (RMS) je naj~e{}i sarkom mekog tkiva u djece mla|e od 15 godina. Prema SZO razlikujemo: em-
brionalni, alveolarni te pleomorfni oblik RMS-a. Ve}ina pacijenata s RMS-om prezentira se tumorskom masom u pod-
ru~ju glave i vrata, genitourinarnog trakta ili donjih ekstremiteta. Rijetko se vidi neobi~na klini~ka prezentacija bolesti
s opse`nom infiltracijom ko{tane sr`i na po~etku bolesti i imitiranjem hematolo{ke neoplazme. Prikazujemo slu~aj
~etrnaestogodi{nje, prethodno zdrave djevoj~ice, koja je hospitalizirana na klinici zbog ambulantno na|enih povi{enih
vrijednosti leukocita. Unazad dva tjedna `alila se na umor, bolove u mi{i}ima, te u~estalu pojavu modrica na ko`i. Kod
prijema u klini~kom statusu na|e se dosta petehija te hematoma na ko`i, pove}an limfni ~vor ingvinalno lijevo, te
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palpabilna slezena 2 cm ispod lijevog rebrenog luka. U laboratorijskim nalazima prisutna leukocitoza, anemija i trom-
bocitopenija. Punkcijom ko{tane sr`i dobije se hipercelularan uzorak ko{tane sr`i uz potisnute sve tri loze hemocito-
poeze i infiltraciju ko{tane sr`i brojnim nezrelim tumorskim stanicama koje su citokemijski i imunocitokemijski po-
zitivne na PAS, vimentin i dezmin, a negativne na LCA, CD20, CD19, CD3, CD10, NSE, Ber EP 4, OIL RED i ANAE.
Uzev{i u obzir morfolo{ke, citokemijske te fenotipske karakteristike mi{ljenje citologa je govorilo da se radi o infiltraciji
ko{tane sr`i stanicama RMS-a. CT-om abdomena na|en je primarni tumor koji ispunjava ~itav retroperitonealni pro-
stor. U~injena biopsija tumora je potvrdila da se radi o rabdomiosarkomu alveolarnog suptipa. Kod infiltracije ko{tane
sr`i primitivnim, nezrelim stanicama diferencijalno dijagnosti~ki treba razmi{ljati i o RMS-u pri ~emu dodatne teh-
nologije (citokemija, imunocitokemija, citogenetska analiza, proto~na citometrija, molekularna analiza) ne samo da
mogu biti od pomo}i ve} u nekim slu~ajevima dovode do definitvne dijagnoze.
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